QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gerhard, R. Articles by Just, I. Search for Related Content PubMed PubMed Citation Articles by Gerhard, R. Articles by Just, I.

Thiol-Modifying Phenylarsine Oxide Inhibits Guanine Nucleotide Binding of Rho but Not of Rac GTPases

Institut für Toxikologie, Medizinische Hochschule Hannover, Hannover, Germany (R.G., I.J.); IPF PharmaCeuticals GmbH, Hannover, Germany (H.J.); Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany (K.A.)

Phenylarsine oxide (PAO) is a phosphotyrosine phosphatase inhibitor that cross-links vicinal thiol groups, thereby inactivating phosphatases possessing XCysXXCysX motifs. The RhoA-GTPase, but not the Rac1-GTPase, also possesses vicinal cysteines within the guanine nucleotide-binding region (aa 13–20) and the phosphohydrolase activity site. Treatment of Caco-2 cells with PAO showed a dose-dependent reorganization of the actin cytoskeleton, indicating involvement of Rho GTPases. As tested by pull-down experiments, RhoA, but not Rac1, from cell lysates was inactivated by PAO in a concentration-dependent manner. Modification of RhoA by PAO resulted in altered mobility on SDS-polyacrylamide gel electrophoresis, and PAO-modified RhoA was no longer substrate for C3-catalyzed ADP-ribosylation. Furthermore, RhoA treated with PAO, but not Rac1 treated with PAO, lost its property to bind to guanine nucleotides. Matrix-assisted laser desorption ionization-mass analysis of PAO-modified RhoA showed a mass shift according to an adduction of a single PAO molecule per molecule RhoA. Further analysis of Glu-C-generated RhoA peptides confirmed binding of PAO to a peptide harboring the guanine nucleotide binding region. Thus, PAO does not exclusively inhibit phosphotyrosine phosphatases but also inactivates RhoA by alteration of nucleotide binding.

Address correspondence to: Ralf Gerhard, Institut für Toxikologie, Medizinische Hochschule, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. E-mail: gerhard.ralf{at}mh-hannover.de

This article has been cited by other articles:

				K. W. Raines, M. G. Bonini, and S. L. Campbell Nitric oxide cell signaling: S-nitrosation of Ras superfamily GTPases Cardiovasc Res, July 15, 2007; 75(2): 229 - 239. [Abstract] [Full Text] [PDF]

				D. Montaudon, K. Palle, L. P. Rivory, J. Robert, C. Douat-Casassus, S. Quideau, M.-A. Bjornsti, and P. Pourquier Inhibition of Topoisomerase I Cleavage Activity by Thiol-reactive Compounds: IMPORTANCE OF VICINAL CYSTEINES 504 AND 505 J. Biol. Chem., May 11, 2007; 282(19): 14403 - 14412. [Abstract] [Full Text] [PDF]

				S. Sokolovski and M. R. Blatt Nitric Oxide Block of Outward-Rectifying K+ Channels Indicates Direct Control by Protein Nitrosylation in Guard Cells Plant Physiology, December 1, 2004; 136(4): 4275 - 4284. [Abstract] [Full Text] [PDF]

				S. N. Bailey, D. M. Sabatini, and B. R. Stockwell From The Cover: Microarrays of small molecules embedded in biodegradable polymers for use in mammalian cell-based screens PNAS, November 16, 2004; 101(46): 16144 - 16149. [Abstract] [Full Text] [PDF]